Mostrando 2 resultados de: 2
Levoketoconazole treatment in endogenous Cushing’s syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes
ArticleAbstract: Objective: This extended evaluation (EE) of the SONICS study assessed the effects of levoketoconazolPalabras claves:Autores:Biller B.M.K., Buchfelder M., Cohen F., Feldt-Rasmussen U., Fleseriu M., Geer E.B., Greenman Y., Heaney A.P., Kennedy L., Pivonello R., Richard J. Auchus, Salvatori R., Zacharieva S.Fuentes:scopusLevoketoconazole: a novel treatment for endogenous Cushing's syndrome
ArticleAbstract: Introduction: Endogenous Cushing’s syndrome (CS) is a rare, life-threatening endocrine disorder thatPalabras claves:cortisol, Cushing’s disease, Cushing’s syndrome, Ketoconazole, levoketoconazole, medical therapy, steroidogenesis inhibitorAutores:Biller B.M.K., Fleseriu M., Pivonello R., Richard J. Auchus, Salvatori R., Zacharieva S.Fuentes:scopus